Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (18)

« Back to Publications

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.

Lippert AH. et al, (2024), Immunity, 57, 256 - 270.e10

The immunology of multiple sclerosis.

Attfield KE. et al, (2022), Nat Rev Immunol, 22, 734 - 750

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis.

Kaufmann M. et al, (2021), Med, 2, 296 - 312.e8

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient.

Wurm H. et al, (2020), Mult Scler, 26, 1261 - 1264

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Faergeman SL. et al, (2020), Cell Death Dis, 11

Structural and regulatory diversity shape HLA-C protein expression levels.

Kaur G. et al, (2017), Nat Commun, 8

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.

Dendrou CA. et al, (2016), Sci Transl Med, 8

Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.

Rühl G. et al, (2016), Neurol Neuroimmunol Neuroinflamm, 3

Class II HLA interactions modulate genetic risk for multiple sclerosis.

Moutsianas L. et al, (2015), Nat Genet, 47, 1107 - 1113

CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis.

Willing A. et al, (2014), Eur J Immunol, 44, 3119 - 3128

TCR transgenic mice that shed light on immune and environmental regulators in multiple sclerosis.

Attfield KE. and Fugger L., (2013), J Immunol, 190, 3015 - 3017

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.

Gregory AP. et al, (2012), Nature, 488, 508 - 511

Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis.

Attfield KE. et al, (2012), Immunol Rev, 248, 10 - 22

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.

Vergo S. et al, (2011), Brain, 134, 571 - 584

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model

Vergo S. et al, (2011), Brain, 134, 571 - 584

Load More